리서치사:Market Glass, Inc. (Formerly Global Industry Analysts, Inc.)
발행일:2024년 08월
페이지 정보:영문 193 Pages
라이선스 & 가격 (부가세 별도)
한글목차
세계의 중재적 신경 기기 시장은 2030년까지 49억 달러에 도달
2023년에 36억 달러로 추정되는 세계의 중재적 신경 기기 시장은 2030년에는 49억 달러에 달하며, 분석 기간인 2023-2030년 CAGR은 4.6%로 성장할 것으로 예측됩니다. 본 리포트에서 분석한 부문의 하나인 뇌색전·동맥류 코일링 디바이스는 CAGR 4.8%를 기록하며, 분석 기간 종료까지 20억 달러에 달할 것으로 예측됩니다. 뇌 혈관성형술 & 스텐트 유치 시스템 분야의 성장률은 분석 기간 중 CAGR 3.1%로 추정됩니다.
미국 시장은 추정 9억 7,430만 달러, 중국은 CAGR 4.3%로 성장 예측
미국의 중재적 신경 기기 시장은 2023년에 9억 7,430만 달러로 추정됩니다. 세계 2위의 경제대국인 중국은 2023-2030년 CAGR 4.3%로 추이하며, 2030년에는 7억 7,360만 달러의 시장 규모에 달할 것으로 예측됩니다. 기타 주목해야 할 지역별 시장으로는 일본과 캐나다가 있으며, 분석 기간 중 CAGR은 각각 4.5%와 3.7%로 예측됩니다. 유럽에서는 독일이 CAGR 3.8%로 성장할 것으로 예측됩니다.
세계의 중재적 신경 기기 시장 - 주요 동향과 촉진요인 정리
중재적 신경 기기란 무엇이며, 왜 신경혈관 장애 치료에 필수적인가?
중재적 신경 기기는 뇌졸중, 동맥류, 동정맥 기형(AVM)과 같은 신경혈관 질환을 최소 침습적으로 치료하는 데 사용되는 특수 의료기기입니다. 카테터, 스텐트, 색전 코일, 혈전 회수 시스템 등 뇌의 복잡하고 섬세한 혈관계통을 통과할 수 있도록 고안된 다양한 기기가 포함됩니다. 중재적 신경학은 환자에게 기존 개복 수술에 비해 덜 침습적인 대안을 제공하여 회복 시간을 단축하고, 합병증 위험을 줄이며, 결과를 개선할 수 있으며, 현대 의학에서 매우 중요한 분야로 자리 잡았습니다. 전 세계에서 신경혈관 질환의 유병률이 지속적으로 증가함에 따라 첨단 중재적 신경 장비에 대한 수요가 증가하고 있으며, 이는 생명을 위협하는 질환을 치료하고 관리하는 데 필수적인 툴로 자리매김하고 있습니다.
기술의 발전은 어떻게 중재적 신경 기기 시장을 형성하고 있는가?
기술의 발전은 특히 영상처리, 카테터 디자인, 재료과학의 혁신을 통해 중재적 신경 기기 시장을 크게 형성하고 있습니다. 고해상도 3D 혈관조영술 및 실시간 수술 중 영상진단과 같은 영상진단 기술의 발전은 뇌혈관계에 대한 상세한 시각화를 제공함으로써 신경혈관 시술의 정확성과 안전성을 향상시키고 있습니다. 보다 유연하고 조종 가능한 카테터의 개발은 중재시술자의 복잡한 동맥 경로를 탐색하는 능력을 향상시켜 혈관 손상 위험을 줄이고 시술 성공률을 향상시키고 있습니다. 생체 적합성 및 방사선 불투과성 재료의 사용을 포함한 재료 과학의 혁신은 스텐트 및 색전 코일과 같은 기구의 안전성과 효능을 향상시켜 복잡한 신경혈관 질환의 치료에 더욱 효과적일 수 있도록 하고 있습니다. 이러한 기술 동향은 신경혈관 질환 환자들에게 보다 효과적이고 덜 침습적인 치료 옵션을 제공하기 위해 의료 환경 전반에 걸쳐 중재적 신경 기기의 채택을 촉진하고 있습니다.
의료 분야에서 중재적 신경 기기에 대한 수요가 증가하는 이유는 무엇인가?
신경혈관 질환의 유병률 증가, 인구 고령화, 최소 침습 수술의 채택률 증가로 인해 헬스케어 분야에서의 중재적 신경 장비에 대한 수요가 증가하고 있습니다. 뇌졸중은 여전히 전 세계 사망과 장애의 주요 원인으로 혈전 제거 장비 및 색전 코일과 같은 효과적인 치료 옵션에 대한 필요성이 증가하고 있습니다. 고령화는 동맥류, AVM 등 첨단 중재적 치료가 필요한 질환의 위험이 높은 고령화도 중재적 신경 장비 수요 증가에 기여하고 있습니다. 환자와 의료진은 개복 수술의 대안으로 회복 시간 단축, 입원 기간 단축, 합병증 발생률 감소를 원하고 있습니다. 또한 중재적 신경과 전문의에 대한 전문 교육이 가능해졌고, 뇌졸중 센터가 확대되면서 복잡한 신경혈관 시술을 시행할 수 있는 의료기관이 증가함에 따라 이러한 장비의 도입이 증가하고 있습니다. 신경혈관 질환의 부담은 계속 증가하고 있으며, 중재적 신경 장비에 대한 수요는 계속 증가할 것으로 예상됩니다.
중재적 신경계 기기 시장의 성장을 가속하는 요인은 무엇인가?
중재적 신경 기기 시장의 성장은 기술 발전, 인구 동향, 최소침습적 치료에 대한 관심 증가 등 여러 가지 요인에 의해 촉진되고 있습니다. 주요 촉진요인 중 하나는 뇌졸중 및 동맥류와 같은 신경혈관 질환의 유병률이 증가하고 있으며, 효과적인 치료를 위해서는 첨단 중재적 치료 장비가 필요하다는 점입니다. 고령자는 중재적 치료가 필요한 신경혈관 질환에 걸리기 쉽기 때문에 세계 인구의 고령화도 큰 성장 요인으로 작용하고 있습니다. 저침습적 시술에 대한 선호도가 높아지면서 시장을 더욱 촉진하고 있습니다. 이러한 시술은 기존 개복 수술에 비해 빠른 회복과 합병증 위험 감소 등 다양한 이점을 제공하기 때문입니다. 영상 처리, 카테터 설계 및 재료의 기술적 발전은 중재적 신경학적 시술의 안전성, 유효성 및 접근성을 향상시킴으로써 시장 성장을 가속하고 있습니다. 또한 의료 인프라에 대한 투자 증가와 뇌졸중 전문센터의 확대로 인해 중재적 신경계 기기 도입에 대한 새로운 기회가 창출되고 있습니다. 이러한 요인들이 헬스케어 환경에 지속적으로 영향을 미치면서, 신경혈관 질환에 대한 효과적이고 진보된 저침습적 치료 옵션에 대한 수요로 인해 중재적 신경 기기 시장은 지속적인 성장을 이룰 것으로 예상됩니다.
조사 대상 기업의 예(총 43건)
Abbott Laboratories
ACANDIS GmbH
B. Braun Melsungen AG
Bayer AG
Biosensors International Group Ltd.
Boston Scientific Corporation
DePuy Synthes
evonos GmbH & Co. KG
Medtronic, Inc.
Merit Medical Systems, Inc.
MicroPort Scientific Corporation
Penumbra, Inc.
Stryker Corporation
Surtex Instruments
Terumo Corporation
W. L. Gore & Associates, Inc.
목차
제1장 조사 방법
제2장 개요
시장 개요
주요 기업
시장 동향과 촉진요인
세계 시장의 전망
제3장 시장 분석
미국
캐나다
일본
중국
유럽
프랑스
독일
이탈리아
영국
기타 유럽
아시아태평양
기타 지역
제4장 경쟁
KSA
영문 목차
영문목차
Global Interventional Neurology Devices Market to Reach US$4.9 Billion by 2030
The global market for Interventional Neurology Devices estimated at US$3.6 Billion in the year 2023, is expected to reach US$4.9 Billion by 2030, growing at a CAGR of 4.6% over the analysis period 2023-2030. Cerebral Embolization & Aneurysm Coiling Device, one of the segments analyzed in the report, is expected to record a 4.8% CAGR and reach US$2.0 Billion by the end of the analysis period. Growth in the Cerebral Angioplasty & Stenting Systems segment is estimated at 3.1% CAGR over the analysis period.
The U.S. Market is Estimated at US$974.3 Million While China is Forecast to Grow at 4.3% CAGR
The Interventional Neurology Devices market in the U.S. is estimated at US$974.3 Million in the year 2023. China, the world's second largest economy, is forecast to reach a projected market size of US$773.6 Million by the year 2030 trailing a CAGR of 4.3% over the analysis period 2023-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 4.5% and 3.7% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 3.8% CAGR.
What Are Interventional Neurology Devices and Why Are They Crucial in Treating Neurovascular Disorders?
Interventional neurology devices are specialized medical instruments used in the minimally invasive treatment of neurovascular disorders, such as strokes, aneurysms, and arteriovenous malformations (AVMs). These devices include catheters, stents, embolization coils, and clot retrieval systems, which are designed to navigate the intricate and delicate vasculature of the brain. Interventional neurology has become a crucial field in modern medicine, as it offers patients less invasive alternatives to traditional open surgeries, leading to faster recovery times, reduced risk of complications, and improved outcomes. As the prevalence of neurovascular disorders continues to rise globally, the demand for advanced interventional neurology devices is increasing, making them essential tools in the treatment and management of these life-threatening conditions.
How Are Technological Advancements Shaping the Interventional Neurology Devices Market?
Technological advancements are significantly shaping the interventional neurology devices market, particularly through innovations in imaging, catheter design, and materials science. Advances in imaging technologies, such as high-resolution 3D angiography and real-time intraoperative imaging, are enhancing the precision and safety of neurovascular procedures by providing detailed visualization of the brain’s vasculature. The development of more flexible and steerable catheters is improving the ability of interventionalists to navigate complex arterial pathways, reducing the risk of vessel injury and improving procedural success rates. Innovations in materials science, including the use of biocompatible and radiopaque materials, are enhancing the safety and efficacy of devices such as stents and embolization coils, making them more effective in treating complex neurovascular conditions. These technological trends are driving the adoption of interventional neurology devices across healthcare settings, as they enable more effective and less invasive treatment options for patients with neurovascular disorders.
Why Is There an Increasing Demand for Interventional Neurology Devices in Healthcare?
The demand for interventional neurology devices is increasing in healthcare due to the growing prevalence of neurovascular disorders, the aging population, and the rising adoption of minimally invasive procedures. Stroke remains a leading cause of death and disability worldwide, driving the need for effective treatment options such as thrombectomy devices and embolization coils. The aging population is also contributing to the demand for interventional neurology devices, as older adults are at higher risk for conditions such as aneurysms and AVMs that require advanced interventional treatment. The trend towards minimally invasive procedures is further fueling demand, as patients and healthcare providers seek alternatives to open surgeries that offer faster recovery times, reduced hospital stays, and lower complication rates. Additionally, the increasing availability of specialized training for interventional neurologists and the expansion of stroke centers are enhancing the adoption of these devices, as more healthcare facilities are equipped to perform complex neurovascular procedures. As the burden of neurovascular diseases continues to grow, the demand for interventional neurology devices is expected to increase.
What Factors Are Driving the Growth in the Interventional Neurology Devices Market?
The growth in the interventional neurology devices market is driven by several factors related to technological advancements, demographic trends, and the increasing focus on minimally invasive treatments. One of the primary drivers is the rising prevalence of neurovascular disorders, such as strokes and aneurysms, which require advanced interventional devices for effective treatment. The aging global population is also a significant growth factor, as older adults are more susceptible to neurovascular conditions that necessitate interventional care. The growing preference for minimally invasive procedures is further propelling the market, as these techniques offer numerous benefits over traditional open surgeries, including faster recovery and reduced risk of complications. Technological advancements in imaging, catheter design, and materials are also driving market growth by improving the safety, efficacy, and accessibility of interventional neurology procedures. Additionally, the increasing investment in healthcare infrastructure and the expansion of specialized stroke centers are creating new opportunities for the adoption of interventional neurology devices. As these factors continue to influence the healthcare landscape, the interventional neurology devices market is expected to experience sustained growth, driven by the need for advanced, effective, and minimally invasive treatment options for neurovascular disorders.
Select Competitors (Total 43 Featured) -
Abbott Laboratories
ACANDIS GmbH
B. Braun Melsungen AG
Bayer AG
Biosensors International Group Ltd.
Boston Scientific Corporation
DePuy Synthes
evonos GmbH & Co. KG
Medtronic, Inc.
Merit Medical Systems, Inc.
MicroPort Scientific Corporation
Penumbra, Inc.
Stryker Corporation
Surtex Instruments
Terumo Corporation
W. L. Gore & Associates, Inc.
TABLE OF CONTENTS
I. METHODOLOGY
II. EXECUTIVE SUMMARY
1. MARKET OVERVIEW
Influencer Market Insights
World Market Trajectories
Interventional Neurology Devices - Global Key Competitors Percentage Market Share in 2024 (E)
Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2024 (E)
Global Economic Update
2. FOCUS ON SELECT PLAYERS
3. MARKET TRENDS & DRIVERS
Growing Incidence of Neurological Disorders Spurs Demand for Interventional Neurology Devices
Advancements in Imaging Technologies Propel Innovation in Neurovascular Interventions
Expansion of Minimally Invasive Surgical Techniques Drives Adoption of Neurology Devices
Shift Towards Catheter-Based Interventions Expands Market Opportunities
Role of Artificial Intelligence in Improving the Precision of Neurological Interventions
Increasing Use of Embolic Protection Devices Strengthens the Business Case for Adoption
Advancements in Thrombectomy Devices Propel Growth in Acute Stroke Management
Growing Importance of Early Diagnosis and Intervention in Neurovascular Conditions
Emerging Markets Present New Opportunities for Interventional Neurology Device Providers
Push for Cost-Effective Solutions in Stroke Treatment and Neurovascular Care
Role of Telemedicine and Remote Monitoring in Supporting Interventional Neurology
Increasing Focus on Patient-Centric Care and Customized Treatment Solutions
Growing Prevalence of Obesity Spurs Demand for Intragastric Balloons
Advancements in Minimally Invasive Weight Loss Solutions Propel Market Growth
Shift Towards Non-Surgical Bariatric Procedures Expands Market Opportunities
Rising Awareness of Obesity-Related Health Risks Drives Adoption of Intragastric Balloons
Increasing Focus on Lifestyle Modification and Weight Management Programs
Role of Multidisciplinary Approaches in Enhancing the Efficacy of Intragastric Balloons
Advancements in Balloon Design and Material Innovation Enhance Patient Safety and Comfort
4. GLOBAL MARKET PERSPECTIVE
TABLE 1: World Interventional Neurology Devices Market Analysis of Annual Sales in US$ Million for Years 2014 through 2030
TABLE 2: World Recent Past, Current & Future Analysis for Interventional Neurology Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
TABLE 3: World Historic Review for Interventional Neurology Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 4: World 16-Year Perspective for Interventional Neurology Devices by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2014, 2024 & 2030
TABLE 5: World Recent Past, Current & Future Analysis for Cerebral Embolization & Aneurysm Coiling by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
TABLE 6: World Historic Review for Cerebral Embolization & Aneurysm Coiling by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 7: World 16-Year Perspective for Cerebral Embolization & Aneurysm Coiling by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
TABLE 8: World Recent Past, Current & Future Analysis for Cerebral Angioplasty & Stenting Systems by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
TABLE 9: World Historic Review for Cerebral Angioplasty & Stenting Systems by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 10: World 16-Year Perspective for Cerebral Angioplasty & Stenting Systems by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
TABLE 11: World Recent Past, Current & Future Analysis for Neurothrombectomy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
TABLE 12: World Historic Review for Neurothrombectomy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 13: World 16-Year Perspective for Neurothrombectomy by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
TABLE 14: World Recent Past, Current & Future Analysis for Support by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
TABLE 15: World Historic Review for Support by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 16: World 16-Year Perspective for Support by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
TABLE 17: World Recent Past, Current & Future Analysis for Cerebral Aneurysm by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
TABLE 18: World Historic Review for Cerebral Aneurysm by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 19: World 16-Year Perspective for Cerebral Aneurysm by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
TABLE 20: World Recent Past, Current & Future Analysis for Strokes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
TABLE 21: World Historic Review for Strokes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 22: World 16-Year Perspective for Strokes by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
TABLE 23: World Recent Past, Current & Future Analysis for Cerebral Artery Stenosis by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
TABLE 24: World Historic Review for Cerebral Artery Stenosis by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 25: World 16-Year Perspective for Cerebral Artery Stenosis by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
TABLE 26: World Recent Past, Current & Future Analysis for Other Therapeutic Areas by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
TABLE 27: World Historic Review for Other Therapeutic Areas by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 28: World 16-Year Perspective for Other Therapeutic Areas by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
III. MARKET ANALYSIS
UNITED STATES
Interventional Neurology Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2024 (E)
TABLE 29: USA Recent Past, Current & Future Analysis for Interventional Neurology Devices by Device - Cerebral Embolization & Aneurysm Coiling, Cerebral Angioplasty & Stenting Systems, Neurothrombectomy and Support - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 30: USA Historic Review for Interventional Neurology Devices by Device - Cerebral Embolization & Aneurysm Coiling, Cerebral Angioplasty & Stenting Systems, Neurothrombectomy and Support Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 31: USA 16-Year Perspective for Interventional Neurology Devices by Device - Percentage Breakdown of Value Sales for Cerebral Embolization & Aneurysm Coiling, Cerebral Angioplasty & Stenting Systems, Neurothrombectomy and Support for the Years 2014, 2024 & 2030
TABLE 32: USA Recent Past, Current & Future Analysis for Interventional Neurology Devices by Therapeutic Area - Cerebral Aneurysm, Strokes, Cerebral Artery Stenosis and Other Therapeutic Areas - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 33: USA Historic Review for Interventional Neurology Devices by Therapeutic Area - Cerebral Aneurysm, Strokes, Cerebral Artery Stenosis and Other Therapeutic Areas Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 34: USA 16-Year Perspective for Interventional Neurology Devices by Therapeutic Area - Percentage Breakdown of Value Sales for Cerebral Aneurysm, Strokes, Cerebral Artery Stenosis and Other Therapeutic Areas for the Years 2014, 2024 & 2030
CANADA
TABLE 35: Canada Recent Past, Current & Future Analysis for Interventional Neurology Devices by Device - Cerebral Embolization & Aneurysm Coiling, Cerebral Angioplasty & Stenting Systems, Neurothrombectomy and Support - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 36: Canada Historic Review for Interventional Neurology Devices by Device - Cerebral Embolization & Aneurysm Coiling, Cerebral Angioplasty & Stenting Systems, Neurothrombectomy and Support Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 37: Canada 16-Year Perspective for Interventional Neurology Devices by Device - Percentage Breakdown of Value Sales for Cerebral Embolization & Aneurysm Coiling, Cerebral Angioplasty & Stenting Systems, Neurothrombectomy and Support for the Years 2014, 2024 & 2030
TABLE 38: Canada Recent Past, Current & Future Analysis for Interventional Neurology Devices by Therapeutic Area - Cerebral Aneurysm, Strokes, Cerebral Artery Stenosis and Other Therapeutic Areas - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 39: Canada Historic Review for Interventional Neurology Devices by Therapeutic Area - Cerebral Aneurysm, Strokes, Cerebral Artery Stenosis and Other Therapeutic Areas Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 40: Canada 16-Year Perspective for Interventional Neurology Devices by Therapeutic Area - Percentage Breakdown of Value Sales for Cerebral Aneurysm, Strokes, Cerebral Artery Stenosis and Other Therapeutic Areas for the Years 2014, 2024 & 2030
JAPAN
Interventional Neurology Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2024 (E)
TABLE 41: Japan Recent Past, Current & Future Analysis for Interventional Neurology Devices by Device - Cerebral Embolization & Aneurysm Coiling, Cerebral Angioplasty & Stenting Systems, Neurothrombectomy and Support - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 42: Japan Historic Review for Interventional Neurology Devices by Device - Cerebral Embolization & Aneurysm Coiling, Cerebral Angioplasty & Stenting Systems, Neurothrombectomy and Support Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 43: Japan 16-Year Perspective for Interventional Neurology Devices by Device - Percentage Breakdown of Value Sales for Cerebral Embolization & Aneurysm Coiling, Cerebral Angioplasty & Stenting Systems, Neurothrombectomy and Support for the Years 2014, 2024 & 2030
TABLE 44: Japan Recent Past, Current & Future Analysis for Interventional Neurology Devices by Therapeutic Area - Cerebral Aneurysm, Strokes, Cerebral Artery Stenosis and Other Therapeutic Areas - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 45: Japan Historic Review for Interventional Neurology Devices by Therapeutic Area - Cerebral Aneurysm, Strokes, Cerebral Artery Stenosis and Other Therapeutic Areas Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 46: Japan 16-Year Perspective for Interventional Neurology Devices by Therapeutic Area - Percentage Breakdown of Value Sales for Cerebral Aneurysm, Strokes, Cerebral Artery Stenosis and Other Therapeutic Areas for the Years 2014, 2024 & 2030
CHINA
Interventional Neurology Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2024 (E)
TABLE 47: China Recent Past, Current & Future Analysis for Interventional Neurology Devices by Device - Cerebral Embolization & Aneurysm Coiling, Cerebral Angioplasty & Stenting Systems, Neurothrombectomy and Support - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 48: China Historic Review for Interventional Neurology Devices by Device - Cerebral Embolization & Aneurysm Coiling, Cerebral Angioplasty & Stenting Systems, Neurothrombectomy and Support Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 49: China 16-Year Perspective for Interventional Neurology Devices by Device - Percentage Breakdown of Value Sales for Cerebral Embolization & Aneurysm Coiling, Cerebral Angioplasty & Stenting Systems, Neurothrombectomy and Support for the Years 2014, 2024 & 2030
TABLE 50: China Recent Past, Current & Future Analysis for Interventional Neurology Devices by Therapeutic Area - Cerebral Aneurysm, Strokes, Cerebral Artery Stenosis and Other Therapeutic Areas - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 51: China Historic Review for Interventional Neurology Devices by Therapeutic Area - Cerebral Aneurysm, Strokes, Cerebral Artery Stenosis and Other Therapeutic Areas Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 52: China 16-Year Perspective for Interventional Neurology Devices by Therapeutic Area - Percentage Breakdown of Value Sales for Cerebral Aneurysm, Strokes, Cerebral Artery Stenosis and Other Therapeutic Areas for the Years 2014, 2024 & 2030
EUROPE
Interventional Neurology Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2024 (E)
TABLE 53: Europe Recent Past, Current & Future Analysis for Interventional Neurology Devices by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
TABLE 54: Europe Historic Review for Interventional Neurology Devices by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 55: Europe 16-Year Perspective for Interventional Neurology Devices by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2014, 2024 & 2030
TABLE 56: Europe Recent Past, Current & Future Analysis for Interventional Neurology Devices by Device - Cerebral Embolization & Aneurysm Coiling, Cerebral Angioplasty & Stenting Systems, Neurothrombectomy and Support - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 57: Europe Historic Review for Interventional Neurology Devices by Device - Cerebral Embolization & Aneurysm Coiling, Cerebral Angioplasty & Stenting Systems, Neurothrombectomy and Support Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 58: Europe 16-Year Perspective for Interventional Neurology Devices by Device - Percentage Breakdown of Value Sales for Cerebral Embolization & Aneurysm Coiling, Cerebral Angioplasty & Stenting Systems, Neurothrombectomy and Support for the Years 2014, 2024 & 2030
TABLE 59: Europe Recent Past, Current & Future Analysis for Interventional Neurology Devices by Therapeutic Area - Cerebral Aneurysm, Strokes, Cerebral Artery Stenosis and Other Therapeutic Areas - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 60: Europe Historic Review for Interventional Neurology Devices by Therapeutic Area - Cerebral Aneurysm, Strokes, Cerebral Artery Stenosis and Other Therapeutic Areas Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 61: Europe 16-Year Perspective for Interventional Neurology Devices by Therapeutic Area - Percentage Breakdown of Value Sales for Cerebral Aneurysm, Strokes, Cerebral Artery Stenosis and Other Therapeutic Areas for the Years 2014, 2024 & 2030
FRANCE
Interventional Neurology Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2024 (E)
TABLE 62: France Recent Past, Current & Future Analysis for Interventional Neurology Devices by Device - Cerebral Embolization & Aneurysm Coiling, Cerebral Angioplasty & Stenting Systems, Neurothrombectomy and Support - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 63: France Historic Review for Interventional Neurology Devices by Device - Cerebral Embolization & Aneurysm Coiling, Cerebral Angioplasty & Stenting Systems, Neurothrombectomy and Support Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 64: France 16-Year Perspective for Interventional Neurology Devices by Device - Percentage Breakdown of Value Sales for Cerebral Embolization & Aneurysm Coiling, Cerebral Angioplasty & Stenting Systems, Neurothrombectomy and Support for the Years 2014, 2024 & 2030
TABLE 65: France Recent Past, Current & Future Analysis for Interventional Neurology Devices by Therapeutic Area - Cerebral Aneurysm, Strokes, Cerebral Artery Stenosis and Other Therapeutic Areas - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 66: France Historic Review for Interventional Neurology Devices by Therapeutic Area - Cerebral Aneurysm, Strokes, Cerebral Artery Stenosis and Other Therapeutic Areas Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 67: France 16-Year Perspective for Interventional Neurology Devices by Therapeutic Area - Percentage Breakdown of Value Sales for Cerebral Aneurysm, Strokes, Cerebral Artery Stenosis and Other Therapeutic Areas for the Years 2014, 2024 & 2030
GERMANY
Interventional Neurology Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2024 (E)
TABLE 68: Germany Recent Past, Current & Future Analysis for Interventional Neurology Devices by Device - Cerebral Embolization & Aneurysm Coiling, Cerebral Angioplasty & Stenting Systems, Neurothrombectomy and Support - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 69: Germany Historic Review for Interventional Neurology Devices by Device - Cerebral Embolization & Aneurysm Coiling, Cerebral Angioplasty & Stenting Systems, Neurothrombectomy and Support Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 70: Germany 16-Year Perspective for Interventional Neurology Devices by Device - Percentage Breakdown of Value Sales for Cerebral Embolization & Aneurysm Coiling, Cerebral Angioplasty & Stenting Systems, Neurothrombectomy and Support for the Years 2014, 2024 & 2030
TABLE 71: Germany Recent Past, Current & Future Analysis for Interventional Neurology Devices by Therapeutic Area - Cerebral Aneurysm, Strokes, Cerebral Artery Stenosis and Other Therapeutic Areas - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 72: Germany Historic Review for Interventional Neurology Devices by Therapeutic Area - Cerebral Aneurysm, Strokes, Cerebral Artery Stenosis and Other Therapeutic Areas Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 73: Germany 16-Year Perspective for Interventional Neurology Devices by Therapeutic Area - Percentage Breakdown of Value Sales for Cerebral Aneurysm, Strokes, Cerebral Artery Stenosis and Other Therapeutic Areas for the Years 2014, 2024 & 2030
ITALY
TABLE 74: Italy Recent Past, Current & Future Analysis for Interventional Neurology Devices by Device - Cerebral Embolization & Aneurysm Coiling, Cerebral Angioplasty & Stenting Systems, Neurothrombectomy and Support - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 75: Italy Historic Review for Interventional Neurology Devices by Device - Cerebral Embolization & Aneurysm Coiling, Cerebral Angioplasty & Stenting Systems, Neurothrombectomy and Support Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 76: Italy 16-Year Perspective for Interventional Neurology Devices by Device - Percentage Breakdown of Value Sales for Cerebral Embolization & Aneurysm Coiling, Cerebral Angioplasty & Stenting Systems, Neurothrombectomy and Support for the Years 2014, 2024 & 2030
TABLE 77: Italy Recent Past, Current & Future Analysis for Interventional Neurology Devices by Therapeutic Area - Cerebral Aneurysm, Strokes, Cerebral Artery Stenosis and Other Therapeutic Areas - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 78: Italy Historic Review for Interventional Neurology Devices by Therapeutic Area - Cerebral Aneurysm, Strokes, Cerebral Artery Stenosis and Other Therapeutic Areas Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 79: Italy 16-Year Perspective for Interventional Neurology Devices by Therapeutic Area - Percentage Breakdown of Value Sales for Cerebral Aneurysm, Strokes, Cerebral Artery Stenosis and Other Therapeutic Areas for the Years 2014, 2024 & 2030
UNITED KINGDOM
Interventional Neurology Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2024 (E)
TABLE 80: UK Recent Past, Current & Future Analysis for Interventional Neurology Devices by Device - Cerebral Embolization & Aneurysm Coiling, Cerebral Angioplasty & Stenting Systems, Neurothrombectomy and Support - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 81: UK Historic Review for Interventional Neurology Devices by Device - Cerebral Embolization & Aneurysm Coiling, Cerebral Angioplasty & Stenting Systems, Neurothrombectomy and Support Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 82: UK 16-Year Perspective for Interventional Neurology Devices by Device - Percentage Breakdown of Value Sales for Cerebral Embolization & Aneurysm Coiling, Cerebral Angioplasty & Stenting Systems, Neurothrombectomy and Support for the Years 2014, 2024 & 2030
TABLE 83: UK Recent Past, Current & Future Analysis for Interventional Neurology Devices by Therapeutic Area - Cerebral Aneurysm, Strokes, Cerebral Artery Stenosis and Other Therapeutic Areas - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 84: UK Historic Review for Interventional Neurology Devices by Therapeutic Area - Cerebral Aneurysm, Strokes, Cerebral Artery Stenosis and Other Therapeutic Areas Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 85: UK 16-Year Perspective for Interventional Neurology Devices by Therapeutic Area - Percentage Breakdown of Value Sales for Cerebral Aneurysm, Strokes, Cerebral Artery Stenosis and Other Therapeutic Areas for the Years 2014, 2024 & 2030
REST OF EUROPE
TABLE 86: Rest of Europe Recent Past, Current & Future Analysis for Interventional Neurology Devices by Device - Cerebral Embolization & Aneurysm Coiling, Cerebral Angioplasty & Stenting Systems, Neurothrombectomy and Support - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 87: Rest of Europe Historic Review for Interventional Neurology Devices by Device - Cerebral Embolization & Aneurysm Coiling, Cerebral Angioplasty & Stenting Systems, Neurothrombectomy and Support Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 88: Rest of Europe 16-Year Perspective for Interventional Neurology Devices by Device - Percentage Breakdown of Value Sales for Cerebral Embolization & Aneurysm Coiling, Cerebral Angioplasty & Stenting Systems, Neurothrombectomy and Support for the Years 2014, 2024 & 2030
TABLE 89: Rest of Europe Recent Past, Current & Future Analysis for Interventional Neurology Devices by Therapeutic Area - Cerebral Aneurysm, Strokes, Cerebral Artery Stenosis and Other Therapeutic Areas - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 90: Rest of Europe Historic Review for Interventional Neurology Devices by Therapeutic Area - Cerebral Aneurysm, Strokes, Cerebral Artery Stenosis and Other Therapeutic Areas Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 91: Rest of Europe 16-Year Perspective for Interventional Neurology Devices by Therapeutic Area - Percentage Breakdown of Value Sales for Cerebral Aneurysm, Strokes, Cerebral Artery Stenosis and Other Therapeutic Areas for the Years 2014, 2024 & 2030
ASIA-PACIFIC
Interventional Neurology Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2024 (E)
TABLE 92: Asia-Pacific Recent Past, Current & Future Analysis for Interventional Neurology Devices by Device - Cerebral Embolization & Aneurysm Coiling, Cerebral Angioplasty & Stenting Systems, Neurothrombectomy and Support - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 93: Asia-Pacific Historic Review for Interventional Neurology Devices by Device - Cerebral Embolization & Aneurysm Coiling, Cerebral Angioplasty & Stenting Systems, Neurothrombectomy and Support Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 94: Asia-Pacific 16-Year Perspective for Interventional Neurology Devices by Device - Percentage Breakdown of Value Sales for Cerebral Embolization & Aneurysm Coiling, Cerebral Angioplasty & Stenting Systems, Neurothrombectomy and Support for the Years 2014, 2024 & 2030
TABLE 95: Asia-Pacific Recent Past, Current & Future Analysis for Interventional Neurology Devices by Therapeutic Area - Cerebral Aneurysm, Strokes, Cerebral Artery Stenosis and Other Therapeutic Areas - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 96: Asia-Pacific Historic Review for Interventional Neurology Devices by Therapeutic Area - Cerebral Aneurysm, Strokes, Cerebral Artery Stenosis and Other Therapeutic Areas Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 97: Asia-Pacific 16-Year Perspective for Interventional Neurology Devices by Therapeutic Area - Percentage Breakdown of Value Sales for Cerebral Aneurysm, Strokes, Cerebral Artery Stenosis and Other Therapeutic Areas for the Years 2014, 2024 & 2030
REST OF WORLD
TABLE 98: Rest of World Recent Past, Current & Future Analysis for Interventional Neurology Devices by Device - Cerebral Embolization & Aneurysm Coiling, Cerebral Angioplasty & Stenting Systems, Neurothrombectomy and Support - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 99: Rest of World Historic Review for Interventional Neurology Devices by Device - Cerebral Embolization & Aneurysm Coiling, Cerebral Angioplasty & Stenting Systems, Neurothrombectomy and Support Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 100: Rest of World 16-Year Perspective for Interventional Neurology Devices by Device - Percentage Breakdown of Value Sales for Cerebral Embolization & Aneurysm Coiling, Cerebral Angioplasty & Stenting Systems, Neurothrombectomy and Support for the Years 2014, 2024 & 2030
TABLE 101: Rest of World Recent Past, Current & Future Analysis for Interventional Neurology Devices by Therapeutic Area - Cerebral Aneurysm, Strokes, Cerebral Artery Stenosis and Other Therapeutic Areas - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 102: Rest of World Historic Review for Interventional Neurology Devices by Therapeutic Area - Cerebral Aneurysm, Strokes, Cerebral Artery Stenosis and Other Therapeutic Areas Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 103: Rest of World 16-Year Perspective for Interventional Neurology Devices by Therapeutic Area - Percentage Breakdown of Value Sales for Cerebral Aneurysm, Strokes, Cerebral Artery Stenosis and Other Therapeutic Areas for the Years 2014, 2024 & 2030